This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Shaping the Future of Medicine… from be6er drugs to 8ssue on-‐demand
Any statements contained in this presentaAon that do not describe historical facts may consAtute forward-‐looking statements as that term is defined in the Private SecuriAes LiAgaAon Reform Act of 1995. Any forward-‐looking statements contained herein are based on current expectaAons, but are subject to a number of risks and uncertainAes. The factors that could cause actual future results to differ materially from current expectaAons include, but are not limited to, risks and uncertainAes relaAng to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company’s products and technology; the availability of substanAal addiAonal funding for the Company to conAnue its operaAons and to conduct research and development, clinical studies and future product commercializaAon; and, the Company's business, research, product development, regulatory approval, markeAng and distribuAon plans and strategies. These and other factors are idenAfied and described in more detail in our filings with the SEC, including our annual report for the period ended December 31, 2012 on Form 10-‐K and our current reports filed on Form 8K. We do not undertake to update these forward-‐looking statements made by us.
3
4
KIDNEY DONORS Data Sources: • USRDS • UNOS
KIDNEY TRANSPLANT WAITLIST
5
KIDNEY DONORS Data Sources: • USRDS • UNOS
KIDNEY TRANSPLANT WAITLIST
PEOPLE WITH END-‐STAGE RENAL FAILURE
PEOPLE WITH MID-‐ TO LATE-‐STAGE CKD
Target Discovery Lead ID Lead Op<miza<on ADMET Development Registra<on
and approval
6
Living human cells are widely used in drug development and regenerative medicine